ESTOC study
Phase 2
Suspended
- Conditions
- Interstitial cystitisD018856bladder, inflammation, pain
- Registration Number
- JPRN-jRCTs051210106
- Lead Sponsor
- Torimoto Kazumasa
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Patients diagnosed as IC
Exclusion Criteria
1) Patients who are allergic to the treatment drug
2) Patients with serious liver disease (AST (GOT) or ALT (GPT) 100 IU / L or higher)
3) Patients who are pregnant or may become pregnant
4) Patients who took the study drug within 3 months before the start of study drug administration
5) Patients who are judged to be inappropriate as subjects by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change of interstitial cystitis symptom scores
- Secondary Outcome Measures
Name Time Method